✦ LIBER ✦

Nondepleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates

✍ Scribed by I. R. Badell; P. W. Thompson; A. P. Turner; M. C. Russell; J. G. Avila; J. A. Cano; J. M. Robertson; F. V. Leopardi; E. A. Strobert; N. N. Iwakoshi; K. A. Reimann; M. L. Ford; A. D. Kirk; C. P. Larsen

Book ID: 114806168
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 949 KB
Volume: 12
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2011.03736.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged anti-CD40 ligand therapy impro

Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival

✍ A.C Chang; M.G Blum; K.S.A Blair; M.A Scott; J.E Brock; D.W Thomas; L.C Burkly; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Alefacept promotes co-stimulation blocka

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

✍ Weaver, Tim A; Charafeddine, Ali H; Agarwal, Avinash; Turner, Alexandra P; Russe 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 462 KB

Portal Venous Donor-Specific Transfusion

Portal Venous Donor-Specific Transfusion in Conjunction with Sirolimus Prolongs Renal Allograft Survival in Nonhuman Primates

✍ K. K. Dhanireddy; D. A. Bruno; T. A. Weaver; H. Xu; X. Zhang; F. V. Leopardi; D. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Effects of dose and duration of anti-CD1

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

✍ H Xu; E Elster; D Batty; J Berning; L Burkly; R Kampen; S Swanson; D Tadaki; D H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Immunological evaluation of combination

Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates

✍ A. Ma; S. Qi; D. Xu; P. Daloze; H. Chen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

A novel calcineurin inhibitor– and sirol

A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates

✍ Idelberto R. Badell; Alexandra P. Turner; Jose A. Cano; Jose G. Avila; Brandi E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB